In vitro Evaluation of Acyclovir/Chitosan Floating Systems
AbstractChitosan (CS) floating lyophilized formulations (L) for gastric drug delivery of acyclovir (ACV) have been developed. The freeze-dried formulations were obtained from acidic aqueous suspensions prepared with different ACV/CS ratios. No changes in ACV crystallinity were observed during X-ray diffraction powder studies as a consequence of the manufacturing process. Considering that fed and fasted states modified the intragastric pH, swelling and in vitro dissolution studies were carried out in different acidic media (0.1 M HCl and progressive pH medium) in order to understand the influence of these physiological states on ACV/CS formulations. Swelling behavior of the floating lyophilized formulations was dependent on CS and ACV proportions within L and on medium nature due to pH dependent CS solubility. Furthermore, no interactions between ACV and CS were detected in solid state according to the X-ray studies. In vitro dissolution of ACV from L was influenced by the swelling behavior. However, it is feasible to optimize the ACV/CS ratios to achieve a desired formulation that releases the total quantity of ACV at a specific time. Moreover, floatability was assessed by buoyancy tests. The results demonstrated that the freeze-drying process achieved effective floating systems capable of remaining within the stomach while the total amount of ACV is released from L.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Ruiz-Caro, R.; Veiga, M.D. In vitro Evaluation of Acyclovir/Chitosan Floating Systems. Materials 2010, 3, 5195-5211.
Ruiz-Caro R, Veiga MD. In vitro Evaluation of Acyclovir/Chitosan Floating Systems. Materials. 2010; 3(12):5195-5211.Chicago/Turabian Style
Ruiz-Caro, Roberto; Veiga, María D. 2010. "In vitro Evaluation of Acyclovir/Chitosan Floating Systems." Materials 3, no. 12: 5195-5211.